%0 Journal Article
%T Honeycomb Epithelial Edema Associated With Rho Kinase Inhibition: A Case Series and Review of the Literature.
%A Lyons LJ
%A Wu KY
%A Baratz KH
%A Sit AJ
%J Cornea
%V 41
%N 2
%D Feb 2022 1
%M 35037906
%F 3.152
%R 10.1097/ICO.0000000000002694
%X <B>UNASSIGNED: </B>The Rho kinase inhibitor netarsudil is a recently approved therapeutic option for the management of increased intraocular pressure in the United States. Although phase 3 clinical trials noted corneal changes related to the medication-namely, nonvisually-significant corneal verticillata-descriptions of a unique form of cystic epithelial edema began to surface as netarsudil (and its sister drug ripasudil, approved in Japan) gained widespread use. This series adds 3 new cases and reviews the current literature on this unique side effect.